I kontrollerede kliniske studier forekom angioødem sjældent under behandling med Enviage, og havde sammenlignelig hyppighed med placebo eller hydrochlorthiazid.
In controlled clinical trials, angioedema occurred rarely during treatment with Enviage with rates comparable to treatment with placebo or hydrochlorothiazide.